Production (Stage)
Hemostemix Inc.
HEM.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.44M | -1.90M | -1.47M | -1.43M | -1.26M |
| Total Depreciation and Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.07M | 685.50K | 377.80K | 450.90K | 394.70K |
| Change in Net Operating Assets | 327.30K | -150.90K | 842.00K | 710.40K | 249.90K |
| Cash from Operations | -1.04M | -1.36M | -245.50K | -265.20K | -614.50K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -101.40K | -- | -- | -- | -- |
| Cash from Investing | -101.40K | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -100.00K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.52M | 2.45M | -- | 320.50K | 724.00K |
| Repurchase of Common Stock | -- | -- | -59.80K | -59.80K | -59.80K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 78.10K | 47.00K | 27.20K |
| Cash from Financing | 1.80M | 1.75M | 13.50K | 229.30K | 440.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 660.30K | 390.20K | -232.00K | -35.90K | -174.00K |